Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[F-18]RGD-K5 PET for monitoring Avastin response
NCT00988936Phase 2Completed
- Sponsor
- Siemens AG
- Start
- Sep 2009
- Primary completion
- Mar 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of flotegatide in non-small cell lung cancer (NSCLC), breast cancer, colorectal cancer (CRC), sponsored by Siemens AG. Started Sep 2009; status: completed.
02
Drugs
flotegatide
03
Conditions
non-small cell lung cancer (NSCLC)breast cancercolorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00988936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00988936.